Josiele Pazinatto

Josiele Pazinatto

Auto-generated profile, based on publicly available information

Josiele Pazinatto

Department of Stomatology, Postgraduate Program in Dentistry, Emphasis on Periodontics Universidade Federal de Santa Maria (UFSM) Santa Maria Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2019 in Brazilian Oral Research
Verified
Journal Article
Open access
PDF file
MCMaísa Casarin
Maísa Casarin
JPJosiele Pazinatto
Josiele Pazinatto
LOLeandro Machado Oliveira
Leandro Machado Oliveira
MSMárcia Ebling de Souza
Márcia Ebling de Souza
Roberto Christ Vianna SantosRoberto Christ Vianna Santos
Roberto Christ Vianna Santos
FZFabricio Batistin Zanatta
Fabricio Batistin Zanatta
Laboratory evidence has demonstrated the antimicrobial effect of Melaleuca alternifolia (MEL) against oral microorganisms. This randomized, double-blind, crossover clinical trial, compared the anti-biofilm and anti-inflammatory effects of MEL nanoparticles with 0.12% chlorhexidine gluconate (CHX) on biofilm-free (BF) and biofilm-covered (BC) surfaces. Before each experimental period, the participants refrained from all oral hygiene practices for 72 hours. The 60 participants were randomly assigned to professional prophylaxis in two quadrants (Q1-Q3 or Q2-Q4), and rinsed with MEL or CHX for four days. The Quigley & Hein plaque index (QHPI), gingival crevicular fluid (GCF) volume, and participants' perceptions were assessed. CHX showed significantly lower mean QHPI on BF (2.65 ± 0.34 vs. 3.34 ± 0.33, p < 0.05) and BC surfaces (2.84 ± 0.37 vs. 3.37 ± 0.33, p < 0.05). Intragroup comparisons indicated reductions in GCF in all the groups, with significant differences only for CHX on BF surfaces (p < 0.05). Intergroup comparisons revealed no significant differences (p > 0.05). Based on individual perceptions, CHX had better taste and biofilm control, but resulted in a greater change in taste. Nevertheless, MEL demonstrated anti-inflammatory effects similar to those of CHX. Further clinical trials testing different protocols, concentrations and follow-up periods are required to establish its clinical application.